Speech-Language Pathologists in Oil City, PA Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Erin Marie Taylor, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Wendy Way, Oil City, PA 16301 Phone: 814-657-4441

Mary Josephine Beers, MACCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1293 Grandview Rd, Oil City, PA 16301 Phone: 814-676-8208

Miss Molly Mcdowell, M.S., CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Vo Tech Dr, Oil City, PA 16301 Phone: 814-676-8686

Ms. Nicole Marie Burns Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1293 Grandview Rd, Oil City, PA 16301 Phone: 814-676-8208

Doni Nicholson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Votech Dr., Oil City, PA 16301 Phone: 814-676-8686

Leigh Pikna, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1293 Grandview Road, Oil City, PA 16301 Phone: 814-676-8208    Fax: 814-677-4877

News Archive

Genentech's obinutuzumab gets FDA Priority Review for chronic lymphocytic leukemia

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for obinutuzumab (GA101) and granted Priority Review for GA101 in the treatment of chronic lymphocytic leukemia, one of the most common forms of blood cancer, based on final Stage 1 data from the pivotal CLL11 trial.

Acorda's GGF2 can improve erectile function after cavernous nerve damage

Acorda Therapeutics, Inc. announced data from a preclinical study showed that treatment with Glial Growth Factor 2 (GGF2) improved erectile function in an animal model following a cavernous nerve (CN) injury, a common complication of prostate surgery.

The Hamner Institutes signs formal Memorandum of Understanding with Oslo Cancer Cluster

The Hamner Institutes at Research Triangle Park has signed a formal Memorandum of Understanding with the Oslo Cancer Cluster in Oslo, Norway, one of the leading cancer clusters in Europe. The goal of the collaboration is to strengthen The Hamner's Global BioScience Gateway for Translational Research and Business Development, which began with partnerships in China.

Accovion establishes two additional subsidiaries in the Czech Republic and in Russia

Accovion is a premier full service European CRO known for its expertise in managing and conducting international clinical trials. Accovion supports local and global projects of all types and phases for the pharmaceutical, biotechnology and medical device industries. Its services include study planning and management, clinical monitoring, pharmacovigilance including post-marketing safety, data management, biostatistics, statistical programming, medical writing and electronic publishing.

Read more Medical News

› Verified 2 days ago